Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel technique for human most cancers remedy | Journal of Nanobiotechnology

0
6


  • Shishodia S, Sethi G, Aggarwal BB: Curcumin: getting again to the roots. Ann N Y Acad Sci. 2005, 1056: 206-217. 10.1196/annals.1352.010.

    CAS 
    Article 

    Google Scholar
     

  • Mohandas KM, Desai DC: Epidemiology of digestive tract cancers in India. V. Massive and small bowel. Indian J Gastroenterol. 1999, 18: 118-121.

    CAS 

    Google Scholar
     

  • Sinha R, Anderson DE, McDonald SS, Greenwald P: Most cancers danger and weight loss plan in India. J Postgrad Med. 2003, 49: 222-228.

    CAS 

    Google Scholar
     

  • Maheshwari RK, Singh AK, Gaddipati J, Srimal RC: A number of organic actions of curcumin: a brief assessment. Life Sci. 2006, 78: 2081-2087. 10.1016/j.lfs.2005.12.007.

    CAS 
    Article 

    Google Scholar
     

  • Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M: Chemopreventive and therapeutic results of curcumin. Most cancers Lett. 2005, 223: 181-190. 10.1016/j.canlet.2004.09.041.

    CAS 
    Article 

    Google Scholar
     

  • Aggarwal BB, Kumar A, Bharti AC: Anticancer potential of curcumin: preclinical and scientific research. Anticancer Res. 2003, 23: 363-398.

    CAS 

    Google Scholar
     

  • Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH: Notch-1 down-regulation by curcumin is related to the inhibition of cell development and the induction of apoptosis in pancreatic most cancers cells. Most cancers. 2006, 106: 2503-2513. 10.1002/cncr.21904.

    CAS 
    Article 

    Google Scholar
     

  • Lev-Ari S, Zinger H, Kazanov D, Yona D, Ben-Yosef R, Starr A, Figer A, Arber N: Curcumin synergistically potentiates the expansion inhibitory and pro-apoptotic results of celecoxib in pancreatic adenocarcinoma cells. Biomed Pharmacother. 2005, 59 (Suppl 2): S276-280. 10.1016/S0753-3322(05)80045-9.

    CAS 
    Article 

    Google Scholar
     

  • Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Worth JE: Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast most cancers cells and inhibits lung metastasis of human breast most cancers in nude mice. Clin Most cancers Res. 2005, 11: 7490-7498. 10.1158/1078-0432.CCR-05-1192.

    CAS 
    Article 

    Google Scholar
     

  • Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G, Xu C, Gopalakrishnan A, Reddy B, Zheng X: Mixed inhibitory results of curcumin and phenethyl isothiocyanate on the expansion of human PC-3 prostate xenografts in immunodeficient mice. Most cancers Res. 2006, 66: 613-621. 10.1158/0008-5472.CAN-05-2708.

    CAS 
    Article 

    Google Scholar
     

  • Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G, Chapman RA, Dulchavsky SA, Gautam SC: Curcumin sensitizes prostate most cancers cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB via suppression of IkappaBalpha phosphorylation. Mol Most cancers Ther. 2004, 3: 803-812.

    CAS 

    Google Scholar
     

  • Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N: Celecoxib and curcumin synergistically inhibit the expansion of colorectal most cancers cells. Clin Most cancers Res. 2005, 11: 6738-6744. 10.1158/1078-0432.CCR-05-0171.

    CAS 
    Article 

    Google Scholar
     

  • Inano H, Onoda M, Inafuku N, Kubota M, Kamada Y, Osawa T, Kobayashi H, Wakabayashi Ok: Chemoprevention by curcumin in the course of the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis. 1999, 20: 1011-1018. 10.1093/carcin/20.6.1011.

    CAS 
    Article 

    Google Scholar
     

  • Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, Cheng AL: Curcumin-containing weight loss plan inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis. 2000, 21: 331-335. 10.1093/carcin/21.2.331.

    CAS 
    Article 

    Google Scholar
     

  • Singh SV, Hu X, Srivastava SK, Singh M, Xia H, Orchard JL, Zaren HA: Mechanism of inhibition of benzo[a]pyrene-induced forestomach most cancers in mice by dietary curcumin. Carcinogenesis. 1998, 19: 1357-1360. 10.1093/carcin/19.8.1357.

    CAS 
    Article 

    Google Scholar
     

  • Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y, Han C, Chen J, Huang MT, Yang CS: Inhibition of seven,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002, 23: 1307-1313. 10.1093/carcin/23.8.1307.

    CAS 
    Article 

    Google Scholar
     

  • Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS: Chemopreventive impact of curcumin, a naturally occurring anti-inflammatory agent, in the course of the promotion/development phases of colon most cancers. Most cancers Res. 1999, 59: 597-601.

    CAS 

    Google Scholar
     

  • Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, Giardiello FM: Mixture therapy with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006, 4: 1035-1038. 10.1016/j.cgh.2006.03.020.

    CAS 
    Article 

    Google Scholar
     

  • Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP: Pharmacodynamic and pharmacokinetic examine of oral Curcuma extract in sufferers with colorectal most cancers. Clin Most cancers Res. 2001, 7: 1894-1900.

    CAS 

    Google Scholar
     

  • Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM: Section I scientific trial of oral curcumin: biomarkers of systemic exercise and compliance. Clin Most cancers Res. 2004, 10: 6847-6854. 10.1158/1078-0432.CCR-04-0744.

    CAS 
    Article 

    Google Scholar
     

  • Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ, Berry DP: Detection of curcumin and its metabolites in hepatic tissue and portal blood of sufferers following oral administration. Br J Most cancers. 2004, 90: 1011-1015. 10.1038/sj.bjc.6601623.

    CAS 
    Article 

    Google Scholar
     

  • Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W: Section I scientific trial of curcumin, a chemopreventive agent, in sufferers with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21: 2895-2900.

    CAS 

    Google Scholar
     

  • Lao CD, Ruffin MTt, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE: Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006, 6: 10-10.1186/1472-6882-6-10.

    Article 

    Google Scholar
     

  • Soni S, Babbar AK, Sharma RK, Maitra A: Supply of hydrophobised 5-fluorouracil by-product to mind tissue via intravenous route utilizing floor modified nanogels. J Drug Goal. 2006, 14: 87-95. 10.1080/10611860600635608.

    CAS 
    Article 

    Google Scholar
     

  • Tyagi R, Lala S, Verma AK, Nandy AK, Mahato SB, Maitra A, Basu MK: Focused supply of arjunglucoside I utilizing floor hydrophilic and hydrophobic nanocarriers to fight experimental leishmaniasis. J Drug Goal. 2005, 13: 161-171.

    CAS 
    Article 

    Google Scholar
     

  • Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R: Nuclear factor-kappaB and IkappaB kinase are constitutively lively in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is related to the suppression of proliferation and the induction of apoptosis. Most cancers. 2004, 101: 2351-2362. 10.1002/cncr.20605.

    CAS 
    Article 

    Google Scholar
     

  • Aggarwal BB, Shishodia S: Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci. 2004, 1030: 434-441. 10.1196/annals.1329.054.

    CAS 
    Article 

    Google Scholar
     

  • Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene merchandise via suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol. 2006, 69: 195-206.

    CAS 

    Google Scholar
     

  • Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, Ikeda O, Mita S, Setoguchi T, Ogawa M: Curcumin inhibits interleukin 8 manufacturing and enhances interleukin 8 receptor expression on the cell floor:affect on human pancreatic carcinoma cell development by autocrine regulation. Most cancers. 2002, 95: 1206-1214. 10.1002/cncr.10812.

    CAS 
    Article 

    Google Scholar
     

  • Shishodia S, Amin HM, Lai R, Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005, 70: 700-713. 10.1016/j.bcp.2005.04.043.

    CAS 
    Article 

    Google Scholar
     

  • Bharti AC, Donato N, Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human a number of myeloma cells. J Immunol. 2003, 171: 3863-3871.

    CAS 
    Article 

    Google Scholar
     

  • Ferrara N: Vascular endothelial development issue and the regulation of angiogenesis. Current Prog Horm Res. 2000, 55: 15-35. dialogue 35–16.

    CAS 

    Google Scholar
     

  • van Vlerken LE, Amiji MM: Multi-functional polymeric nanoparticles for tumour-targeted drug supply. Professional Opin Drug Deliv. 2006, 3: 205-216. 10.1517/17425247.3.2.205.

    CAS 
    Article 

    Google Scholar
     

  • Torchilin VP: Micellar nanocarriers: pharmaceutical views. Pharm Res. 2007, 24: 1-16. 10.1007/s11095-006-9132-0.

    CAS 
    Article 

    Google Scholar
     

  • Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC: Block copolymer micelles: preparation, characterization and software in drug supply. J Management Launch. 2005, 109: 169-188. 10.1016/j.jconrel.2005.09.034.

    CAS 
    Article 

    Google Scholar
     

  • Torchilin VP: Focused polymeric micelles for supply of poorly soluble medicine. Cell Mol Life Sci. 2004, 61: 2549-2559. 10.1007/s00018-004-4153-5.

    CAS 
    Article 

    Google Scholar
     

  • Kwon GS: Polymeric micelles for supply of poorly water-soluble compounds. Crit Rev Ther Drug Service Syst. 2003, 20: 357-403. 10.1615/CritRevTherDrugCarrierSyst.v20.i5.20.

    CAS 
    Article 

    Google Scholar
     

  • Panyam J, Labhasetwar V: Biodegradable nanoparticles for drug and gene supply to cells and tissue. Adv Drug Deliv Rev. 2003, 55: 329-347. 10.1016/S0169-409X(02)00228-4.

    CAS 
    Article 

    Google Scholar
     

  • Gradishar WJ: Albumin-bound paclitaxel: a next-generation taxane. Professional Opin Pharmacother. 2006, 7: 1041-1053. 10.1517/14656566.7.8.1041.

    CAS 
    Article 

    Google Scholar
     

  • Singh S, Khar A: Organic results of curcumin and its position in most cancers chemoprevention and remedy. Anticancer Brokers Med Chem. 2006, 6: 259-270.

    CAS 
    Article 

    Google Scholar
     

  • Aggarwal BB, Shishodia S: Molecular targets of dietary brokers for prevention and remedy of most cancers. Biochem Pharmacol. 2006, 71: 1397-1421. 10.1016/j.bcp.2006.02.009.

    CAS 
    Article 

    Google Scholar
     

  • Choudhuri T, Pal S, Das T, Sa G: Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 section of cell cycle in a p53-dependent method. J Biol Chem. 2005, 280: 20059-20068. 10.1074/jbc.M410670200.

    CAS 
    Article 

    Google Scholar
     

  • Tong QS, Zheng LD, Lu P, Jiang FC, Chen FM, Zeng FQ, Wang L, Dong JH: Apoptosis-inducing results of curcumin derivatives in human bladder most cancers cells. Anticancer Medication. 2006, 17: 279-287. 10.1097/00001813-200603000-00006.

    CAS 
    Article 

    Google Scholar
     

  • Ramachandran C, You W: Differential sensitivity of human mammary epithelial and breast carcinoma cell strains to curcumin. Breast Most cancers Res Deal with. 1999, 54: 269-278. 10.1023/A:1006170224414.

    CAS 
    Article 

    Google Scholar
     

  • Syng-Ai C, Kumari AL, Khar A: Impact of curcumin on regular and tumor cells: position of glutathione and bcl-2. Mol Most cancers Ther. 2004, 3: 1101-1108.

    CAS 

    Google Scholar
     

  • Jiang MC, Yang-Yen HF, Yen JJ, Lin JK: Curcumin induces apoptosis in immortalized NIH 3T3 and malignant most cancers cell strains. Nutr Most cancers. 1996, 26: 111-120.

    CAS 
    Article 

    Google Scholar
     

  • Li L, Braiteh FS, Kurzrock R: Liposome-encapsulated curcumin: in vitro and in vivo results on proliferation, apoptosis, signaling, and angiogenesis. Most cancers. 2005, 104: 1322-1331. 10.1002/cncr.21300.

    CAS 
    Article 

    Google Scholar
     

  • Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM: The curry spice curcumin reduces oxidative injury and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001, 21: 8370-8377.

    CAS 

    Google Scholar
     

  • Park SY, Kim DS: Discovery of pure merchandise from Curcuma longa that defend cells from beta-amyloid insult: a drug discovery effort towards Alzheimer’s illness. J Nat Prod. 2002, 65: 1227-1231. 10.1021/np010039x.

    CAS 
    Article 

    Google Scholar
     

  • Ono Ok, Hasegawa Ok, Naiki H, Yamada M: Curcumin has potent anti-amyloidogenic results for Alzheimer’s beta-amyloid fibrils in vitro. J Neurosci Res. 2004, 75: 742-750. 10.1002/jnr.20025.

    CAS 
    Article 

    Google Scholar
     

  • Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM: Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005, 280: 5892-5901. 10.1074/jbc.M404751200.

    CAS 
    Article 

    Google Scholar
     

  • Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du Ok, Lukacs GL, Caplan MJ: Curcumin, a significant constituent of turmeric, corrects cystic fibrosis defects. Science. 2004, 304: 600-602. 10.1126/science.1093941.

    CAS 
    Article 

    Google Scholar
     

  • Lipecka J, Norez C, Bensalem N, Baudouin-Legros M, Planelles G, Becq F, Edelman A, Davezac N: Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 community. J Pharmacol Exp Ther. 2006, 317: 500-505. 10.1124/jpet.105.097667.

    CAS 
    Article 

    Google Scholar
     

  • Davis PB, Drumm ML: Some prefer it sizzling: curcumin and CFTR. Tendencies Mol Med. 2004, 10: 473-475. 10.1016/j.molmed.2004.08.001.

    CAS 
    Article 

    Google Scholar
     

  • Feldmann G, Beaty RM, Hruban RH, Maitra A: Molecular genetics of pancreatic intraepithelial neoplasia. J Hepatobiliary Pancreat Surg. 2006,


    Google Scholar
     

  • Karikari CA, Mullendore M, Eshleman JR, Argani P, Leoni LM, Chattopadhyay S, Hidalgo M, Maitra A: Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers. Mol Most cancers Ther. 2005, 4: 1860-1866. 10.1158/1535-7163.MCT-05-0103.

    CAS 
    Article 

    Google Scholar
     

  • LEAVE A REPLY

    Please enter your comment!
    Please enter your name here